Han Min Cheol, Choi Seo Hee, Hong Chae-Seon, Kim Yong Bae, Koom Woong Sub, Kim Jin Sung, Cho Jaeho, Wee Chan Woo, Kim Changhwan, Park Jong Won, Han Soorim, Lee Heejeong, Yoon Hong In, Lee Ik Jae, Keum Ki Chang
Department of Radiation Oncology, Heavy Ion Therapy Research Institute, Yonsei Cancer Center, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Republic of Korea.
Department of Radiation Oncology, Heavy Ion Therapy Research Institute, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea.
Radiat Oncol J. 2024 Dec;42(4):295-307. doi: 10.3857/roj.2024.00206. Epub 2024 Dec 20.
This report offers a detailed examination of the inception and current state of the Heavy-ion Therapy Center (HITC) at the Yonsei Cancer Center (YCC), setting it apart as the world's first center equipped with a fixed beam and two superconducting gantries for carbon-ion radiation therapy (CIRT).
Preparations for CIRT at YCC began in 2013; accordingly, this center has completed a decade of meticulous planning and culminating since the operational commencement of the HITC in April 2023.
This report elaborates on the clinical preparation for adopting CIRT in Korea. It includes an extensive description of HITC's facility layout at YCC, which comprises the accelerator and treatment rooms. Furthermore, this report delineates the clinical workflow, criteria for CIRT application, and the rigorous quality assurance processes implemented at YCC. It highlights YCC's sophisticated radiation therapy infrastructure, collaborative initiatives, and the efficacious treatment of >200 prostate cancer cases utilizing CIRT.
This manuscript concludes by discussing the prospective influence of CIRT on the medical domain within Korea, spotlighting YCC's pioneering contribution and forecasting the widespread integration of this groundbreaking technology.
本报告详细审视了延世癌症中心(YCC)重离子治疗中心(HITC)的创立及现状,该中心是世界上首个配备固定束流和两个用于碳离子放射治疗(CIRT)的超导龙门架的中心。
YCC于2013年开始筹备CIRT;因此,自HITC于2023年4月投入运营以来,该中心已完成了十年的精心规划并达到最终阶段。
本报告阐述了韩国采用CIRT的临床准备情况。它详细描述了YCC的HITC设施布局,包括加速器和治疗室。此外,本报告还描述了临床工作流程、CIRT应用标准以及YCC实施的严格质量保证流程。它突出了YCC先进的放射治疗基础设施、合作举措以及利用CIRT有效治疗200多例前列腺癌病例。
本手稿最后讨论了CIRT对韩国医学领域的潜在影响,突出了YCC的开创性贡献,并预测了这项开创性技术的广泛应用。